Daniel Vasella
Daniel Vasella
Daniel Lucius Vasella, M.D.is a medical doctor, author, and executive who served as CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure the Novartis shares declined 10%, below the industry...
growth increased investment key level marketing percent priority resulted sales
Our increased level of investment in marketing and sales, with the priority on key growth drivers, resulted in a sales growth of 21 percent in Pharmaceuticals in the U.S.,
anticipate dynamic fourth full growth looking operating quarter resulting sales softer solid somewhat third
Looking ahead, we anticipate a somewhat softer third quarter and, again, a more dynamic fourth quarter resulting in mid-single-digit sales growth... and solid operating growth for the full year,
although areas discussed explore hope time
At present, no collaboration has been discussed with Roche management, although we hope that over time we will be able to explore areas of collaboration.
healthy larger litigation
Litigation is potentially much larger when you vaccinate healthy people.
plan turn vaccines
Our plan is to turn around the Chiron vaccines business,
concerned europe human resources
If you can't find the human resources in Europe you go elsewhere. As a European, I'm concerned for Europe.
answer
It is a hypothetical question. I don't answer hypothetical questions.
achieving based confident objectives record robust sales
Based on the robust results, we are are confident of achieving our full-year objectives for new record sales and earnings.
address customer demand health increase meet plan public quality require research turn vaccines
Our plan is to turn around the Chiron vaccines business, which will require investments in research and development, and manufacturing, to increase quality and capacity, so that we can better meet customer demand and address public health needs,
continue expect gain growth market slow
Market growth in 2006 will slow down somewhat. I expect that we will be able to continue to gain market share.
fix problems quality quantity
We first want to fix the quality and quantity problems which are at hand.
confident delivering dynamic growth record sales year
We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings.